About OrthoSpace
OrthoSpace is a company based in Caesarea (Israel) founded in 2009 by Assaf Dekel was acquired by Stryker in March 2019. OrthoSpace has raised $23.6 million across 5 funding rounds from investors including Stryker, Smith & Nephew and HealthpointCapital. OrthoSpace operates in a competitive market with competitors including Miach Orthopaedics, Rotation Medical, Cayenne Medical, Biorez and Nanochon, among others.
- Headquarter Caesarea, Israel
- Founders Assaf Dekel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of OrthoSpace
OrthoSpace has successfully raised a total of $23.6M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OrthoSpace
OrthoSpace has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker, Smith & Nephew and HealthpointCapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
HealthpointCapital is focused on private equity in musculoskeletal healthcare.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early stage healthcare startups
|
Locked | Locked | Locked | |
|
Manufacturer of knee, hip and shoulder joint replacements
|
Locked | Locked | Locked |
Investor details for OrthoSpace
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OrthoSpace
Investment portfolio details for OrthoSpace
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OrthoSpace
Detailed financials for OrthoSpace
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orthospace Comparisons
Peer comparison for OrthoSpace
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OrthoSpace
OrthoSpace operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Miach Orthopaedics, Rotation Medical, Cayenne Medical, Biorez and Nanochon, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Bio-engineered surgical implants for connective tissue repair are developed.
|
|
| Locked | Locked | Locked |
A rotator cuff repair system is developed for disease treatment.
|
|
| Locked | Locked | Locked |
Soft tissue reconstruction solutions for knee and shoulder
|
|
| Locked | Locked | Locked |
Bioresorbable scaffolds for ACL soft tissue regeneration are developed.
|
|
| Locked | Locked | Locked |
3D-printed implants are developed for treating joint injuries.
|
Detailed competitors of OrthoSpace
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orthospace
Complete news archive for OrthoSpace
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OrthoSpace
OrthoSpace was founded in 2009.
OrthoSpace is headquartered in Caesarea, Israel. It is registered at Caesarea, Haifa, Israel.
OrthoSpace is a funded company, having raised a total of $23.6M across 5 funding rounds to date.
OrthoSpace develops and commercializes a biodegradable balloon system, InSpace, which is deployed using minimally invasive techniques. The shoulder is a complicated joint that requires the interconnected functioning of tendons, ligaments and bones. The InSpace Balloon, which is implanted between the acromion and the humeral head, creates a space between the bone structures(acromion and humeral head), allowing smooth and frictionless gliding. The system is designed to create a physical barrier between tissues in the subacromial space. The company claims that the InSpace biodegradable balloon system emulates the activity of the normal bursa and offers patients less pain, and a shorter rehabilitation period. As of 2016, The InSpace System has the CE mark and is commercially available in Europe.
OrthoSpace's top competitors include Miach Orthopaedics, Nanochon and ZuriMED Technologies.
OrthoSpace has 5 investors. Key investors include Stryker, Smith & Nephew, HealthpointCapital, Johnson & Johnson Innovation, and Triventures.